COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,869 Articles (22,568 medRxiv, 8,301 bioRxiv)

Most recent first Previous |  Page 2012: Articles 20111-20120  | Next

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
Mehalko, J., Drew, M., Snead, K., Denson, J.-P., Wall, V., Taylor, T., Sadtler, K., Messing, S., Gillette, W., Esposito, D.
10.1101/2020.11.18.388868 — Posted: 2020-11-18
Long-chain polyphosphates impair SARS-CoV-2 infection and replication: a route for therapy in man
Ferrucci, V., Dae, Y. K., Asadzadeh, F., Marrone, L., Siciliano, R., Cerino, P., Criscuolo, G., Pisano, I., Quarantelli, F., Izzo, B., Fusco, G., Comegna, M., Boccia, A., Viscardi, M., Borriello, G., Brandi, S., Pierri, B. M., Tiberio, C., Atripaldi, L., Paolella, G., Castaldo, G., Pascarella, S., Bianchi, M., Della Monica, R., Chiariotti, L., Yun, K. S., Cheong, J. H., Kim, H. Y., Zollo, M.
10.1101/2020.11.18.388413 — Posted: 2020-11-18 Discussion: Onsite
Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 in vitro
Le-Trilling, V. T. K., Mennerich, D., Schuler, C., Flores-Martinez, Y., Katschinski, B., Dittmer, U., Trilling, M.
10.1101/2020.11.18.388710 — Posted: 2020-11-18
COVID-19-associated olfactory dysfunction reveals SARS-CoV-2 neuroinvasion and persistence in the olfactory system
De Melo, G. D., Lazarini, F., Levallois, S., Hautefort, C., Michel, V., Larrous, F., Verillaud, B., Aparicio, C., Wagner, S., Gheusi, G., Kergoat, L., Kornobis, E., Cokelaer, T., Hervochon, R., Madec, Y., Roze, E., Salmon, D., Bourhy, H., Lecuit, M., Lledo, P.-M.
10.1101/2020.11.18.388819 — Posted: 2020-11-18 Discussion: Onsite | Offsite
The expression of PDCD1 and CD274 in T cells and macrophages correlated positively with COVID-19 severity
Gao, Q., Liu, S., Ding, R., Chen, H., Dong, X., Xie, J., Li, Y., Chen, L., Liu, H., Mu, F.
10.1101/2020.11.17.378992 — Posted: 2020-11-18
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines
Quinlan, B. D., Li, W., Mou, H., Zhang, L., Chang, J., Peng, S., Ojha, A., Tavora, R., Parcells, M. S., Luo, G. G., Li, W., Zhong, G., Choe, H., Farzan, M.
10.1101/2020.11.18.388934 — Posted: 2020-11-18
Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma
Vandeberg, P., Cruz, M., Diez, J. M., Merritt, W. K., Santos, B., Trukawinski, S., Wellhouse, A., Jose, M., Willis, T.
10.1101/2020.11.18.388991 — Posted: 2020-11-18
HLA class I genotypes customize vaccination strategies in immune simulation to combat COVID-19
Huang, S., Tan, M.
10.1101/2020.11.18.388983 — Posted: 2020-11-18
Formulation of a composite nasal spray enabling enhanced surface coverage and prophylaxis of SARS-COV-2
Moakes, R. J. A., Davies, S. P., Stamataki, Z., Grover, L. M.
10.1101/2020.11.18.388645 — Posted: 2020-11-18 Discussion: Onsite | Offsite
In-vitro virucidal activity of hypothiocyanite and hypothiocyanite/lactoferrin mix against SARS-CoV-2
Cegolon, L., Mirandola, M., Salaris, C., Salvati, M. V., Salata, C., Mastrangelo, G.
10.1101/2020.11.17.387571 — Posted: 2020-11-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).